FAKTOR-OPTIONSSCHEIN - BRISTOL-MYERS SQUIBB | Market Closed - Börse Stuttgart 09:53:06 2024-05-31 am EDT | ||
| 54.92 EUR | +3.21% |
|
| Current month | +141.19% | ||
| 1 month | +141.19% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Latest news about BRISTOL-MYERS SQUIBB COMPANY
More news
| Date | Price | Change |
|---|---|---|
| 24-05-31 | 54.92 | +3.21% |
| 24-05-30 | 53.21 | -8.26% |
| 24-05-29 | 58 | +20.98% |
| 24-05-28 | 47.94 | +12.25% |
| 24-05-27 | 42.71 | -1.25% |
Delayed Quote Börse Stuttgart
Last update May 31, 2024 at 09:53 am EDT
More quotesStatic data
| Product type | Warrant Esotici e Strutturati |
|---|---|
| Buy / Sell | CALL |
| Underlying | BRISTOL-MYERS SQUIBB COMPANY |
| Issuer | 
Société Générale
|
| WKN | SN7D2T |
| ISIN | DE000SN7D2T5 |
| Date issued | 2022-07-28 |
| Strike | 73.59 $ |
| Maturity | Unlimited |
| Parity | 1 : 1 |
| Emission price | 10.24 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 58 € |
|---|---|
| Lowest since issue | 1.46 € |
| Spread | 0.66 € |
| Spread % | 1.45% |
Company Profile
Bristol-Myers Squibb Company est spécialisé dans le développement, la fabrication et la commercialisation de produits pharmaceutiques. Les produits sont destinés au traitement des cancers, des maladies cardio-vasculaires, de l'hépatite, des maladies immunitaires et des désordres psychiatriques.
The United States account for 70.1% of net sales.
Sector
-
Ratings for Bristol-Myers Squibb Company
Trading Rating
Investor Rating
ESG Refinitiv
B
Consensus: Bristol-Myers Squibb Company
Sell
Buy
Mean consensus
HOLD
Number of Analysts
26
Last Close Price
41.09
USD
Average target price
53.19
USD
Spread / Average Target
+29.46%
- Stock Market
- Certificates
- Certificat
